Send us Feedback

Abraxis BioScience (ABII)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
STOCK CHART
Financials
SEC FILINGS

ABII » Topics » (9) Accumulated Other Comprehensive Loss

This excerpt taken from the ABII 8-K filed Nov 8, 2007.

(9) Accumulated Other Comprehensive Loss

At June 30, 2007 and 2006, New Abraxis had cumulative foreign currency translation gain adjustments of $0.2 million and $0.1 million, respectively. In addition, at June 30, 2007 and December 31, 2006, New Abraxis had cumulative unrealized gains on marketable equity securities of $0.7 million and $2.1 million, respectively.

"(9) Accumulated Other Comprehensive Loss" elsewhere:

Biomira (BIOM)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki